Literature DB >> 8138520

The efficacy of psychoanalysis for children with disruptive disorders.

P Fonagy1, M Target.   

Abstract

OBJECTIVE: This paper describes a chart review of 763 cases of child psychoanalysis and psychotherapy at the Anna Freud Centre, and illustrates its usefulness by examining predictors of treatment outcome in children with disruptive disorders.
METHOD: 135 children and adolescents with a principal diagnosis of disruptive disorder were individually matched with others suffering from emotional disorders. Outcome was indicated by diagnostic change and change in overall adaptation (clinically significant improvement or return to normal functioning).
RESULTS: Improvement rates were significantly higher for the emotional than for the disruptive group. Within the disruptive group, significant improvement was more frequent among children with oppositional defiant disorder (56%) than those with attention deficit hyperactivity disorder (36%) or conduct disorder (23%). However, 31% of the children terminated treatment within 1 year. Of those disruptive children who remained in treatment more than 1 year, 69% were no longer diagnosable on termination. Fifty-eight percent of the variance in outcome ratings could be accounted for within this group. The crucial variables in predicting attrition and symptomatic improvement were found to be quite different in the disruptive and emotional groups.
CONCLUSION: Although the study has several methodological limitations, it does suggest demographic, clinical, and diagnostic characteristics of those disruptive children most likely to benefit from intensive and nonintensive psychodynamic treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8138520     DOI: 10.1097/00004583-199401000-00007

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  12 in total

Review 1.  Parent management of attendance and adherence in child and adolescent therapy: a conceptual and empirical review.

Authors:  Matthew K Nock; Caitlin Ferriter
Journal:  Clin Child Fam Psychol Rev       Date:  2005-06

2.  Psychoanalysis today.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

3.  Rejoinder to Mordock's critique of the Fort Bragg Evaluation Project: the sample is generalizable and the outcomes are clear.

Authors:  L Bickman; M S Salzer; E W Lambert; R Saunders; W T Summerfelt; C A Heflinger; K Hamner
Journal:  Child Psychiatry Hum Dev       Date:  1998

Review 4.  The Fort Bragg continuum of care Demonstration Project: the population served was unique and the outcomes are questionable.

Authors:  J B Mordock
Journal:  Child Psychiatry Hum Dev       Date:  1997

Review 5.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

6.  Is more better than less? An analysis of children's mental health services.

Authors:  E M Foster
Journal:  Health Serv Res       Date:  2000-12       Impact factor: 3.402

Review 7.  Social anxiety disorder in childhood and adolescence: current status and future directions.

Authors:  T B Kashdan; J D Herbert
Journal:  Clin Child Fam Psychol Rev       Date:  2001-03

8.  Psychosocial therapies for children and adolescents: overview and future directions.

Authors:  D J Cohen
Journal:  J Abnorm Child Psychol       Date:  1995-02

9.  Predictors of outcome in infant and toddlers functional or behavioral disorders after a brief parent-infant psychotherapy.

Authors:  M J Hervé; M Paradis; C Rattaz; S Lopez; V Evrard; M White-Koning; M Maury
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-05-19       Impact factor: 4.785

10.  Community vs. clinic-based modular treatment of children with early-onset ODD or CD: a clinical trial with 3-year follow-up.

Authors:  David J Kolko; Lorah D Dorn; Oscar G Bukstein; Dustin Pardini; Elizabeth A Holden; Jonathan Hart
Journal:  J Abnorm Child Psychol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.